MedTrace Logo

Safety Study of Alfalastin (Human Alpha-1 Antitrypsin) Administered at Home

NCT01676688 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2023-10-03

No results posted yet for this study

Summary

The purpose of this study is to collect safety data on ALFALASTIN® infusions performed at home or in out-of hospital locations.

Conditions

Sponsors & Collaborators

  • Laboratoire français de Fractionnement et de Biotechnologies

    lead INDUSTRY

Principal Investigators

  • Cuvelier Antoine, Prof. · Pneumology - CHU Rouen, France

  • Mornex Jean-François, Prof · Pneumology - CHU Lyon, France

  • Thabut Gabriel, MD · Pneumology - Hôpital Bichat Paris, France

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2012-09-30
Completion
2012-10-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01676688 on ClinicalTrials.gov